Bavarian Nordic A/S
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000D6P1V7
BAVA
Bavarian Nordic A/S
GICS: 35201010
·
Sector: Health Care
·
Sub-Sector: Health Care
NAME
Bavarian Nordic A/S
ISIN
DK0015998017
TICKER
BAVA
MIC
XCSE
REUTERS
BAVA.CO
BLOOMBERG
BAVA DC
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
In this section you will find transaction histories for short sales.
ai
NALIZER
Short sellers are obliged to report when building up positions from 0.50% and when reducing positions up to 0.50%. If there are open positions >= 0.50% in the reporting registers, these are shown in the following overview.
Twelve Short sale positions >= 0.50% are currently registered as reportable-relevant
| Date | Position Holder | Position | # | Action |
|---|---|---|---|---|
| 15.11.2024 | PDT Partners LLC | 0,70% | 26 | |
| 30.10.2024 | Millennium International Management LP | 0,58% | 153 | |
| 12.09.2024 | Point72 Asset Management, LP | 0,55% | 3 | |
| 03.09.2024 | Citadel Advisors LLC | 0,58% | 12 | |
| 30.08.2024 | Qube Research & Technologies Ltd | 0,55% | 75 | |
| 15.08.2024 | Arrowstreet Capital Limited Partnership | 0,50% | 97 | |
| 08.08.2024 | Marshall Wace LLP | 0,50% | 187 | |
| 19.04.2024 | WorldQuant LLC | 0,50% | 115 | |
| 07.02.2024 | Balyasny Asset Management (UK) LLP | 0,71% | 4 | |
| 06.10.2023 | Balyasny Europe Asset Management LLP | 0,59% | 27 | |
| 23.11.2022 | Lone Pine Capital LLC | 0,69% | 3 | |
| 24.04.2018 | AHL Partners LLC | 1,65% | 1 |
The overview shows all positions and their last reported status. Please note that when reducing positions, falling below the 0.50% limit means that the mandatory reporting obligations no longer have to be applied. As a rule, it can be assumed that the positions have been completely reduced following a longer period of inactivity. Positions < 0.50% are therefore only of limited significance.
| Date | Position Holder | Position | # | Action |
|---|---|---|---|---|
| 15.11.2024 | PDT Partners LLC | 0,70% | 26 | |
| 30.10.2024 | Millennium International Management LP | 0,58% | 153 | |
| 12.09.2024 | Point72 Asset Management, LP | 0,55% | 3 | |
| 03.09.2024 | Citadel Advisors LLC | 0,58% | 12 | |
| 30.08.2024 | Qube Research & Technologies Ltd | 0,55% | 75 | |
| 15.08.2024 | Arrowstreet Capital Limited Partnership | 0,50% | 97 | |
| 08.08.2024 | Marshall Wace LLP | 0,50% | 187 | |
| 19.04.2024 | WorldQuant LLC | 0,50% | 115 | |
| 07.02.2024 | Balyasny Asset Management (UK) LLP | 0,71% | 4 | |
| 06.10.2023 | Balyasny Europe Asset Management LLP | 0,59% | 27 | |
| 23.11.2022 | Lone Pine Capital LLC | 0,69% | 3 | |
| 25.10.2022 | Capital Fund Management | 0,46% | 64 | |
| 01.08.2022 | Deep Track Biotechnology Master Fund, Ltd. | 0,43% | 4 | |
| 19.07.2022 | D. E. Shaw & Co., L.P. | 0,49% | 4 | |
| 30.05.2022 | KYNAM CAPITAL MANAGEMENT, LP | 0,47% | 5 | |
| 24.05.2022 | AHL Partners LLP | 0,48% | 53 | |
| 20.05.2022 | Adage Capital Management L.P. | 0,26% | 11 | |
| 17.11.2020 | Systematica Investments Limited | 0,49% | 12 | |
| 03.04.2020 | Guevoura Fund Limited | 0,00% | 8 | |
| 02.04.2020 | Pentwater Capital Management LP | 0,00% | 13 | |
| 30.07.2019 | Connor Clark & Lunn Investment Management Ltd | 0,49% | 22 | |
| 09.04.2019 | Voleon Capital Management LP | 0,49% | 10 | |
| 28.03.2019 | Citadel Advisors II LLC | 0,48% | 46 | |
| 16.07.2018 | AXA Investment Managers Chorus Limited | 0,49% | 18 | |
| 28.06.2018 | GSA Capital Partners LLP | 0,49% | 20 | |
| 19.06.2018 | Oxford Asset Management | 0,49% | 24 | |
| 24.04.2018 | AHL Partners LLC | 1,65% | 1 | |
| 09.03.2018 | Point72 Europe (London) LLP | 0,41% | 6 | |
| 15.09.2017 | Perceptive Advisors LLC | 0,38% | 3 | |
| 03.04.2017 | Bogle Investment Management, L.P. | 0,49% | 6 | |
| 09.08.2016 | Macquarie Funds Management Hong Kong Limited | 0,49% | 2 | |
| 11.05.2016 | Man Investments Limited | 0,00% | 5 | |
| 16.11.2015 | Kerrisdale Advisers LLC | 0,19% | 18 |
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.
